To test whether the mitochondrial respiratory chain complex III is necessary for T~reg~ cell survival, proliferation, or function, we crossed animals harboring a loxP-flanked *Uqcsrf1* gene, which encodes the Rieske iron-sulfur protein (RISP), an essential subunit of mitochondrial complex III^[@R8]^, with *Foxp3*^*YFP-Cre*^ mice^[@R9]^ to generate animals specifically lacking RISP in T~reg~ cells (RISP KO). Efficient loss of RISP in T~reg~ cells was confirmed by immunoblot ([Fig. 1a](#F1){ref-type="fig"}, For gel source data, see [Supplementary Figure 1](#SD1){ref-type="supplementary-material"}), accompanied by diminished oxygen consumption rate (OCR) with concomitant increase in glycolytic flux (ECAR) ([Fig. 1b,c](#F1){ref-type="fig"}). RISP KO mice did not survive past the fourth week of life and exhibited signs of significant inflammation by 3 weeks of age including thymic atrophy, enlargement of lymph nodes and spleens along with lymphocytic infiltration into multiple organs ([Figure 1d--f](#F1){ref-type="fig"}, [Extended Data Fig. 1a--d](#F5){ref-type="fig"}). Moreover, RISP KO mice displayed substantial increases in activated CD4^+^ and CD8^+^ T cells in the lymph nodes and spleen ([Extended Data Fig. 1e--h](#F5){ref-type="fig"}). RISP KO mice at 10 days post-natal did not display any inflammatory changes or thymic atrophy ([Extended Data Fig. 2a--d](#F6){ref-type="fig"}). Overall, the phenotype exhibited by RISP KO animals is reminiscent of mice completely deficient in T~reg~ cells^[@R10]--[@R12]^; however, the number of CD4^+^ Foxp3^+^ CD25^+^ cells was unchanged in the spleen and modestly elevated in the lymph nodes in RISP KO animals ([Fig. 1g](#F1){ref-type="fig"}, [Extended Data Fig. 2e](#F6){ref-type="fig"}).

RISP KO animals had fewer CD25^lo^ T~reg~ cells, while CD25 expression was elevated on RISP KO CD25^+^ Foxp3^+^ cells compared to wild-type cells ([Fig. 1g](#F1){ref-type="fig"}, [Extended Data Fig. 2e](#F6){ref-type="fig"}, [3a](#F7){ref-type="fig"}). Expression of additional hallmark T~reg~ cell markers, CTLA-4, GITR, and EOS were also increased in RISP-deficient T~reg~ cells relative to wild-type cells while HELIOS expression was unchanged [(Extended Data Fig. 3b,c)](#F7){ref-type="fig"}. Furthermore, T~reg~ cells deficient in RISP displayed increased surface expression of activation markers and similar rates of proliferation, by Ki-67 staining, relative to wild-type cells [(Extended Data Fig. 3d,e)](#F7){ref-type="fig"} and had similar percentages of central and effector T~reg~ cells [(Extended Data Fig. 3f,g)](#F7){ref-type="fig"}. Interestingly, T~reg~ cells from RISP KO animals had significantly reduced suppressive capacity in vivo and in vitro compared to wild-type cells ([Fig. 1h](#F1){ref-type="fig"}, [Extended Data Fig. 3h,i](#F7){ref-type="fig"}). To further corroborate these results, we crossed animals harboring a floxed *Uqcrq* gene (encodes for QPC protein, [Extended Data Fig. 4a](#F8){ref-type="fig"}), another subunit of complex III, to the *Foxp3*^*YFP-Cre*^ animals. As with T~reg~ cell specific loss of RISP, loss of QPC in T~reg~ cells diminishes OCR and increases ECAR, and results in premature death of the mouse but maintains T~reg~ cell numbers [(Extended Data Fig. 4b-p)](#F8){ref-type="fig"}.

To further examine whether loss of complex III after development impairs T~reg~ cell function, we generated mice harboring the *Uqcrq floxed*, *Foxp3*^*GFP-CreERT2*^, and *ROSA26Sor*^*CAG-tdTomato*^ alleles (QPC iKO). In these animals, GFP marks cells actively expressing *Foxp3* while tdtomato-RFP identifies cells which have undergone cre-recombinase-mediated loss of *Uqcrq*. Six weeks after 8-week-old mice where treated with 3 doses of tamoxifen, Treg cells exhibited diminished levels of QPC mRNA and OCR concomitant with an increase in ECAR ([Fig. 2a--c](#F2){ref-type="fig"}). Furthermore, upon continuous tamoxifen treatment these animals developed signs of systemic inflammation and significant elevations in activated CD4^+^ and CD8^+^ T cells within 28 days ([Fig. 2d,e](#F2){ref-type="fig"}; [Extended Data Fig. 5a--d](#F9){ref-type="fig"}). RFP expression was observed in T~reg~ cells, but not in other immune cell types or thymic epithelial cells, suggesting that a loss of T~reg~ cell suppressive function drives the observed inflammatory changes ([Extended Data Fig. 5e,f](#F9){ref-type="fig"}).

To determine if loss of Foxp3 expression was driving the pathology observed in these mice, we administered adult mice 3 doses of tamoxifen and assessed for tdtomato-RFP^+^ and Foxp3-GFP^+^ co-expression 12 weeks later. QPC iKO animals displayed no alteration in spleen and lymph node cellularity after 3 months ([Extended Data Fig. 5g,h](#F9){ref-type="fig"}). However, QPC iKO mice did have a decrease in the percentage of GFP^+^RFP^+^ cells with a concurrent increase in the GFP^+^RFP^−^ cells suggesting QPC iKO animals produce more new T~reg~ cells after the discontinuation of tamoxifen relative to WT animals ([Fig. 2f](#F2){ref-type="fig"}, [Extended Data Fig. 5i](#F9){ref-type="fig"}). Importantly, the ratio of GFP^−^RFP^+^ cells to GFP^+^RFP^+^ cells was unchanged in the iKO animals demonstrating that the stability of Foxp3 expression was not altered by loss of complex III ([Fig. 2g](#F2){ref-type="fig"}). Next, we examined the suppressive function of QPC-null T~reg~ cells in the context of tumor immunity. B16 melanoma cells were able to generate tumors in WT mice following tamoxifen treatment, but not in mice that harbor T~reg~ cells deficient in QPC ([Fig. 2h](#F2){ref-type="fig"}). Collectively, these data demonstrate that complex III function is necessary for T~reg~ cell suppressive function independent of Foxp3.

To investigate mechanisms of impaired suppressive function in complex III-deficient T~reg~ cells, we performed transcriptional profiling of CD4^+^ Foxp3-YFP^+^ CD25^+^ cells isolated from RISP KO and WT mice. We observed extensive alterations in gene expression due to loss of RISP in T~reg~ cells ([Extended Data Fig. 6a--c](#F10){ref-type="fig"}). Importantly, numerous genes including *Nrp1*^[@R13]^~,~ *Pdcd1* (encodes PD-1)^[@R14]^, *Nt5e* (encodes CD73)^[@R15]^, *Tigit*^[@R16]^ and *Flg2*^[@R17]^ were significantly reduced (Adj. *p*\<1 × 10^−7^) in T~reg~ cells lacking RISP ([Extended Data Fig. 6d](#F10){ref-type="fig"}). Surface expression of Nrp1, PD-1, CD73 and Tigit was reduced on T~reg~ cells lacking RISP relative to wild-type cells and occurred independently of changes in activation status ([Extended Data Fig. 6e](#F10){ref-type="fig"}, [Extended Data Fig. 3g](#F7){ref-type="fig"}). To verify that these changes in gene expression were a cell autonomous effect of complex III deficiency and not a secondary consequence of the profound inflammation observed in RISP KO mice, we generated chimeric animals by producing female mice that were homozygous for the floxed *Uqcrsf1* allele and heterozygous for *Foxp3*^*YFP-Cre*^ (RISP chimeric KO, YFP marks cells with active cre-recombinase). Following random inactivation of the X-chromosome in these mice, the T~reg~ cell compartment contains a mix of RISP-sufficient *Foxp3*-YFP^−^ and RISP-deficient *Foxp3*-YFP^+^ cells. RISP chimeric KO mice display no obvious inflammatory phenotype and had normal spleen and lymph node cellularity ([Extended Data Fig. 7a,b](#F11){ref-type="fig"}). In addition, the number of CD4^+^, CD8^+^, Foxp3-YFP^+^ T~reg~ cells, and Foxp3-YFP^−^ T~reg~ cells was unchanged in RISP chimeric KO relative to RISP wild-type chimeric animals ([Fig. 3a](#F3){ref-type="fig"}; [Extended Data Fig. 7c,d](#F11){ref-type="fig"}). However, the ratio of Foxp3-YFP^+^ to Foxp3-YFP^−^ T~reg~ cells and the ratio of expression of activation markers CD44 and ICOS on these cells were decreased in RISP chimeric KO mice compared to RISP chimeric WT suggesting that RISP KO T~reg~ cells may be outcompeted by wild-type T~reg~ cells in vivo ([Extended Data Fig. 7e,f](#F11){ref-type="fig"}). Interestingly, the expression of CTLA-4 was unchanged between the knockout and wild-type cells in RISP chimeric KO and RISP chimeric WT mice ([Extended Data Fig. 7g](#F11){ref-type="fig"}). RNA sequencing revealed changes in gene expression due to loss of RISP in the chimeric mice including genes associated with T~reg~ cells ([Fig. 3b,c](#F3){ref-type="fig"}; [Extended Data Fig. 7h--j](#F11){ref-type="fig"}). Importantly, only a subset of downregulated genes in RISP deficient T~reg~ cells isolated from chimeric mice overlapped with the RISP KO T~reg~ cells demonstrating that the decreased expression of these particular genes is a cell autonomous effect due to loss of mitochondrial complex III, independent of host inflammatory conditions ([Extended Data Fig. 7k](#F11){ref-type="fig"}).

DNA methylation has been shown to critically influence T~reg~ cell fate and function through Foxp3-dependent and -independent mechanisms^[@R18],[@R19]^. Thus, to assess DNA methylation we performed modified reduced representation bisulfite sequencing (mRRBS)^[@R20]^ on CD25^+^ T~reg~ cells from RISP KO and RISP WT mice. Globally, DNA methylation around gene loci was not altered in T~reg~ cells deficient in RISP ([Extended Fig. 8a](#F12){ref-type="fig"}). In addition, RISP KO T~reg~ cells did not display a global change in CpG methylation at T~reg~-specific super-enhancers or at the *Foxp3* locus super-enhancer specifically ([Extended Data Fig. 8b,c](#F12){ref-type="fig"})^[@R21]^. DNA methylation was mildly increased around the transcription start site (TSS) of genes determined to be differentially downregulated by RNA-seq (log~FC~≤2, FDR\<.05), and further increased around differentially downregulated genes that contained CpG islands near their TSS ([Extended Data Fig. 8d,e](#F12){ref-type="fig"}). Next, we examined DNA methylation in T~reg~ cells isolated from RISP chimeric KO and WT mice. mRRBS and an unsupervised analysis identified 17,588 differentially methylated CpGs (DMCs); chimeric KO Treg cells were predominantly hypermethylated compared to chimeric WT T~reg~ cells at these positions ([Fig. 3d](#F3){ref-type="fig"}). Of the gene loci associated with DMCs, 150 loci were differentially expressed ([Extended Data Fig. 8f](#F12){ref-type="fig"}). T~reg~-specific super-enhancer elements did not display differential methylation ([Fig. 3e](#F3){ref-type="fig"}); however, chimeric RISP KO T~reg~ cells showed hypermethylation at gene loci whose expression was down-regulated ([Extended Data Fig. 8g](#F12){ref-type="fig"}). [Extended data figure 8h](#F12){ref-type="fig"} shows the methylation status of gene loci hypermethylated in chimeric RISP KO Treg cells. Collectively, these data suggest that loss of mitochondrial complex III results in DNA hypermethylation and altered gene expression without affecting the methylation status of canonical Treg cell genes, including *Foxp3*.

We have previously demonstrated that loss of mitochondrial complex III in cancer and hematopoietic stem cells results in elevated levels of 2-hydroxyglutarate (2-HG) and succinate^[@R22]^. IDH1 and IDH2 mutant cancer cells produce high levels of D(R)-2-HG, while normal cells produce L(*S*)-2-HG from promiscuous substrate usage of α-KG by lactate dehydrogenase or malate dehydrogenase under hypoxia, loss of VHL or mitochondrial electron transport chain inhibition due to a decrease in NAD+/NADH ratio^[@R23]--[@R26]^. Succinate and 2-HG function as antagonists of the α-KG-dependent dioxygenases including the TETs^[@R27],[@R28]^. We examined metabolite levels in CD25^+^ T~reg~ cells from RISP KO mice. NAD+/NADH ratio was decreased while succinate and 2-HG levels were significantly elevated in RISP and QPC KO T~reg~ cells relative to wild-type cells ([Fig. 4a,b](#F4){ref-type="fig"}; [Extended Data Fig. 9a,b](#F13){ref-type="fig"}). The levels of dihydroorate and glycerol-3-phosphate were elevated in RISP KO cells consistent with a loss of complex III function ([Extended Data Fig. 9c](#F13){ref-type="fig"}). Citrate and aspartate are necessary for de novo lipogenesis and nucleotides, respectively were unchanged consistent with the lack of a proliferation defect seen in RISP KO T~reg~ cells ([Extended Data Fig. 9d](#F13){ref-type="fig"}).

It is possible that the increase in glycolysis might have resulted in gene expression changes in RISP-deficient T~reg~ cells. However, GLUT1-overexpressing T~reg~ cells that display high glycolytic flux and reduced suppressive capacity had very little overlap with the RISP-deficient T~reg~ cells isolated from chimeric mice ([Extended Data Fig. 10a](#F14){ref-type="fig"})^[@R5]^. Furthermore, WT Treg cells ex vivo treated for 24 hours with individual mitochondrial respiratory chain inhibitors targeting complex I (Piercidin), II (3-NPA), and III (Antimycin A) displayed diminished OCR yet different levels of 2-HG and succinate accumulation along with differential gene expression ([Fig. 4c,d](#F4){ref-type="fig"}; [Extended Data Fig. 10b](#F14){ref-type="fig"}). Complex III inhibition by antimycin A was the only inhibitor that caused an increase in both succinate and 2-HG levels ([Fig. 4c](#F4){ref-type="fig"}) and displayed the most profound changes in gene expression ([Fig. 4d](#F4){ref-type="fig"}). These results suggest respiratory chain inhibition at different complexes results in differential metabolite changes to cause distinct gene expression changes. It will be interesting in future studies to determine whether the conditional loss of different respiratory chain complexes within T~reg~ cells causes distinct pathologies in mice.

Methods {#S1}
=======

Animal Models {#S2}
-------------

C57BL/6 *Uqcrfs*^*fl/fl*^ (RISP^*fl/fl*^) are previously described^[@R8]^. C57BL/6 mice harboring a loxp-flanked exon 1 of the *Uqcrq* gene (encodes QPC, QPC^*fl/fl*^ mice) were generated by Ozgene (locus map in [Extended Data Figure 4a](#F8){ref-type="fig"}). The *frt-*flanked neomycin resistance cassette was removed by crossing QPC^*fl/fl*^ mice to mice expressing FLP-recombinase (FLPo Mice Jackson Lab, Stock no. 011065). Loss of the Neo-cassette was confirmed using PCR. QPC^*fl/fl*^ mice were genotyped using the following primers: 1. 5'-CTTCCGCTCCTCCCGGAAGT-3', 2. 5'-TTCCCAAACTCGCGGCCCATG-3' and 3. 5'-CAATTCCAGCCAACAGTCCC-3' which allow identification of the *Uqcrq* wild-type, loxp-flanked, and excised alleles. RISP^*fl/fl*^ and QPC^*fl/fl*^ mice were checked for C57BL/6 status and both are \>99% C57BL/J using the genome scanning service from Jackson Laboratories. *Foxp3*^*YFP-Cre*^ (stock no. 016959), *Foxp3*^*eGFP-Cr-eERT2*^ (stock no. 016961), and *ROSA26Sor*^*CAG-tdTomato*^ (Ai14, stock no. 007908) mice were obtained from Jackson Laboratory. 40 mg/ml tamoxifen dissolved in corn oil was administered to mice every third day using oral gavage to reach an effective dose of 320mg/kg in 8 to 12-week old mice. All animal procedures were approved by Institutional Animal Care and Use Committee (IACUC) at Northwestern University.

Flow cytometry and Cell Sorting {#S3}
-------------------------------

Spleen, lymph nodes (always included all superficial and periaortic lymph nodes) and thymus were harvested from 10-day post-natal, 3-week-old and adult (8--12-week-old) mice. To obtain a single-cell suspension, tissues were disrupted using scored 60-mm petri dishes in PBS containing 2% FBS and filtered through a 70-μM nylon mesh filter. Total spleen, lymph node, and thymus counts were obtained using the Cellometer K2 Counter using AOPI stain (Nexcelom). Single cell suspensions were stained with antibodies against CD45.2 (Clone: 104), CD4 (Clone: RM4--5), CD8 (Clone: 53--6.7), CD25 (Clone: PC61.5), CD44 (Clone: IM7), CD62L (Clone: MEL-14) to obtain absolute cell numbers. For intracellular protein expression, samples were fixed using the Foxp3/Transcription Factor Staining Buffer Set (Invitrogen Catalog no. 00-5523-00) according to the manufactures instructions and stained with Foxp3 (Clone: NRRF-30), HELIOS (Clone: 22F6), and EOS (Clone: ESB7C2) and Ki-67 (Clone: SalA15). CD4^+^ T cells were purified from single cell suspension using the EasySep™ mouse CD4^+^ T cell isolation Kit (Stemcell, Catalog no. 19852) according to the manufactures instructions. CD4^+^ T cells were further stained with antibodies against CTLA-4 (Clone: UC10--4B9), GITR (Clone: DTA-1), ICOS (Clone: C398.4A), OX40 (Clone: OX-86), CD69 (Clone: H1.2F3), CD103 (Clone: 2E7), Nrp1 (Clone: 3DS304M), CD73 (Clone: TY/11.8), PD-1 (Clone: 29F.1A12), and Tigit (Clone: GIGD7). All samples were analyzed on LSR Fortessa flow cytometers (BD) and data was analyzed using FlowJo software. Cells were sorted using a custom SORP FASC Aria II (BD).

Cell Culture {#S4}
------------

In vitro T~reg~ cell suppression assays were performed using the protocol described by Collison *et al*.^[@R29]^ Briefly, CD4^+^ Foxp3-YFP^+^ CD25^+^ cells were isolated and co-cultured with differing quantities of CD8^+^ T cell cells labeled with Cell Trace Violet (ThermoFisher, Catalog no. C34557) according to the manufactures instructions. T~reg~ cell-CD8^+^ T cell co-cultures were activated using CD3/CD28 MACSiBead particles (Miltenyi) at a ratio of three beads to one CD8^+^ T effector cell. After 72 hours, cells were harvested and analyzed by flow cytometry. The division index of each samples was calculated using the proliferation function in FlowJo software. For T~reg~ cell culture in vitro, CD4^+^ Foxp3-YFP^+^ CD25^+^ cells were freshly isolated using FACS sorting and cultured using the Mouse Treg Expansion Kit beads (Miltenyi, Catalog no. 130-095-925) following the manufacture's protocol. In short, 100,000 CD25^+^ T~reg~ cells were cultured with 300,000 pre-loaded CD3/CD28 MACSiBead particles and 4000U/ml recombinant human IL-2 (NCI at Frederick Preclinical Repository. All cell culture experiments were performed in RPMI 1640 (Corning) supplemented with 10% Nu-Serum (Corning), 1% Hepes (Corning), 1% Glutamax (Gibco), 1% Antibiotic/Antimycotic (Corning), 1% MEM non-essential amino acids (Corning), 1 mM methyl pyruvate (Sigma, Catalog no. 371173), 400 μM Uridine and 50 μM β-mercaptoethanol. Mitochondrial inhibitors Piericidin, 3-NPA and Antimycin A were all obtained from Sigma.

Protein extraction and Immunblot {#S5}
--------------------------------

CD4^+^ Foxp3-YFP^+^ CD25^+^ cells were collected using fluorescence-activated cell sorting. Following isolation, cells were lysed in cell lysis buffer (Cell Signaling), resolved on 12% polyacrylamide gels (Bio-Rad) and transferred to nitrocellulose membranes. Membranes were blocked using 5% milk for 1 hour and then incubated with anti-RISP (Mitosciences, catalog no. ab14746; used at 1:250 dilution) and anti-β-actin (Sigma, catalog no. T9026; used at 1:2000 dilution) overnight. Membranes were washed with TBST the next day and then incubated with goat anti-mouse IRDye 680RD (Li-cor, catalog no. C50721, 1:5,000 dilution) and goat anti-rabbit IRDye 800CW (Li-cor, catalog no. C60321; 1:10,000 dilution) for one hour. Following another TBST wash the membranes were directly imaged using the Odyssey Fc Analyzer (Li-cor).

RNA Isolation and real time PCR {#S6}
-------------------------------

RNA was isolated using the RNeasy plus micro kit (Qiagen) following the manufacturer's instructions. RNA was converted to cDNA using the RETROscript Reverse Transcription Kit in accordance with the manufactures instruction. Real time PCR was performed on the CFX384 Real Time System (Bio-rad) using iQ SYBR Green Supermix (Bio-rad) and 200 nM (final concentration) of the follow primers: *Uqcrq*-F 5'-CACGCGTCTATCTTCTGTCC −3', *Uqcrq*-R 5'-CTGAAATAGCTTGGGAAGGC-3', Rpl19-F 5'-GAAGGTCAAAGGGAATGTGTTCAA-3' Rpl19-R 5'-TTTCGTGCTTCCTTGGTCTTAGA-3'. Data were analyzed using the comparative CT method (ΔΔCt method)^[@R30]^.

RNA-seq analysis {#S7}
----------------

Cells were lysed with RLT Buffer from the Qiagen RNeasy Plus Mini kit (Qiagen). Cell lysates were stored at −80°C until RNA was extracted. RNA isolations were performed using Qiagen RNeasy Plus Micro/Mini kit (Qiagen) [(Extended Data Fig. 6)](#F10){ref-type="fig"} or the AllPrep DNA/RNA Micro Kit (Qiagen) ([Figure 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}, [Extended Data Fig. 7](#F11){ref-type="fig"},[8](#F12){ref-type="fig"}) following the manufacturer's protocol with an additional on-column DNase treatment using the RNase-Free DNase Set (Qiagen). RNA quality and quantity were measured using Agilent 4200 Tapestation using the high-sensitivity RNA ScreenTape System (Agilent Technologies). mRNA libraries were prepared using the SMART-Seq v4 Ultra Low Input RNA Kit (Takara Bio USA, Inc) +Nextera XT DNA sample preparation kit (Illumina Inc) [(Extended Data Fig. 6)](#F10){ref-type="fig"} or the NEBNext Ultra I RNA Library Prep Kit for Illumina with poly (A) mRNA selection (NEB Inc) ([Figure 3](#F3){ref-type="fig"},[4](#F4){ref-type="fig"}, [Extended Data 7](#F11){ref-type="fig"}). DNA libraries were sequenced on an Illumina NextSeq 500 instrument (Illumina Inc) with a target read depth of approximately 30 million aligned reads per sample. The pool was denatured and diluted, resulting in a 2.5 pM DNA solution. PhiX control was spiked at 1% and the pool was sequenced by 1×75 cycles using NextSeq 500 High Output reagent kit V2 (Illumina Inc). FASTQ reads were trimmed using Trimmomatic to remove end nucleotides with a PHRED score less than 30 and requiring a minimum length of 20 bp. Reads were then aligned to the mm10 genome using tophat version 2.1.0^[@R31]^ using the following options \--no-novel-juncs \--read-mismatches 2 \--read-edit-dist 2 \--max-multihits 20--library-type fr-unstranded. The generated bam files were then used to count the reads only at the exons of genes using htseq-count^[@R32]^ with the following parameters -q -m intersection-nonempty -s no -t exon. Differential expression analysis was performed using the R/Bioconductor package edgeR^[@R33]^. Bigwig tracks of RNA-Seq expression were generated by using the GenomicAlignments package in R in order to calculate the coverage of reads in counts per million (CPM) normalized to the total number of uniquely mapped reads for each sample in the library. Gene set enrichment analysis was done using the Broad Institute GSEA software^[@R34]^. In brief, the gene list output from edgeR was ranked by calculating a rank score of each gene as −log 10 (PValue)\*sign(logFC). A pre-ranked GSEA analysis was done using 3000 permutations and the Hallmark pathway database. To specifically assess the alterations in T~reg~ cell signature gene expression, we used a T~reg~ cell gene expression pattern defined in a previous study^[@R35]^.

DNA methylation analysis {#S8}
------------------------

Genomic DNA was isolated using the AllPrep DNA/RNA Micro Kit (Qiagen). To assess genome-wide DNA methylation status, we performed reduced representation bisulfite sequencing with modifications (mRRBS)^[@R36]^. Following fluorometric quantification with a Qubit 3.0 instrument, genomic DNA was subjected to restriction endonuclease digestion with MspI (New England Biolabs) and size selected for fragments approximately 100--250 base pairs in length using solid phase reversible immobilization (SPRI) beads (MagBio Genomics). Resulting DNA underwent bisulfite conversion with the EZ DNA Methylation-Lightning Kit (Zymo Research) per the manufacturer's protocol. The efficiency of our bisulfite conversion reaction averaged \> 99% as assessed by C→T conversion at CpG motifs in un-methylated λ-bacteriophage DNA spike-in controls (New England BioLabs N3013S). We then used the Pico Methyl-Seq Library Prep Kit (Zymo Research) to create indexed Illumina-compatible non-directional libraries from bisulfite-converted single-stranded DNA. The libraries were then pooled for sequencing on an Illumina NextSeq 500 instrument using the NextSeq 500/550 V2 High Output reagent kit (1 × 75 cycles) to obtain a minimum read depth of 50 million reads/sample.

Demultiplexing was accomplished with bcl2fastq v2.17.1.14 followed by trimming (using TrimGalore!^[@R37]^ v0.4.3) of 10 base pairs from the 5' end to remove primer and adapter sequences. Sequence alignment to the GRCm38/mm10 reference genome and methylation calls were performed with Bismark^[@R38]^ v0.16.3. Bismark coverage (counts) files for cytosines in CpG context were generated using Bismark. These files were then analyzed with the DSS v2.14.0 R/Bioconductor package^[@R39]^ (R v3.4.1) for differential methylation and quantification. Cumulative distribution plots were generated with the ecdf base R function, and Venn diagrams were created with the VennDiagram v1.6.17 R package. K-means clustering and heatmaps were generated using the Morpheus web interface (The Broad Institute)^[@R40]^.

SeqMonk v1.38.2 was used for data visualization and quantitation using the bisulphite methylation over features pipeline for the sliding window approach as described in the text and figure legends where applicable. Transcriptional start sites (TSS) were obtained from the Ensembl Genes 90 database and filtered for those with a Consensus CDS ID. Methylation around CpG island-containing genes was determined by filtering for windows overlapping less than 0.1 kb from a CpG island (MGI database) and examining behavior around TSSs of differentially expressed genes. All computational analysis was performed using "Genomics Nodes" on Quest, Northwestern University's High-Performance Computing Cluster. Specific statistical testing procedures are elaborated in the text and figure legends, performed either in R using packages specified above or in GraphPad Prism v7.02.

Metabolite measurements and analysis {#S9}
------------------------------------

CD4^+^ Foxp3-YFP^+^ CD25^+^ were isolated, washed once with .9% NaCl which was subsequently removed, and frozen in liquid nitrogen. Following collection of all samples over multiple days, samples were thawed on ice and suspended in 50 μl of ice-cold 80% methanol per 200,000 cells. Samples were frozen in liquid nitrogen and thawed in a 37C water bath three times. Following that, cells were centrifuged at 18,000×g for 10 minutes at 4C. The supernatant was transferred to fresh tubes and dried. Samples were resuspended in 10 μl per 150,000 cells. Samples were analyzed by High-Performance Liquid Chromatography and High-Resolution Mass Spectrometry and Tandem Mass Spectrometry (HPLC-MS/MS). Specifically, the system consisted of a Thermo Q-Exactive in line with an electrospray source and an Ultimate3000 (Thermo) series HPLC consisting of a binary pump, degasser, and auto-sampler outfitted with an Xbridge Amide column (Waters; dimensions of 4.6 mm × 100 mm and a 3.5-μm particle size). The mobile phase A contained 95% (vol/vol) water, 5% (vol/vol) acetonitrile, 20 mM ammonium hydroxide, 20 mM ammonium acetate, pH = 9.0; B was 100% acetonitrile. The gradient was as following: 0--1 min, 15% A; 18.5 min, 76% A; 18.5--20.4 min, 24% A; 20.4--20.5 min, 15% A; 20.5--28 min, 15% A with a flow rate of 400 μL/min. The capillary of the ESI source was set to 275 °C, with sheath gas at 45 arbitrary units, auxiliary gas at 5 arbitrary units and the spray voltage at 4.0 kV. In positive/negative polarity switching mode, an m/z scan range from 70 to 850 was chosen and MS1 data was collected at a resolution of 70,000. The automatic gain control (AGC) target was set at 1 × 10^6^ and the maximum injection time was 200 ms. The top 5 precursor ions were subsequently fragmented, in a data-dependent manner, using the higher energy collisional dissociation (HCD) cell set to 30% normalized collision energy in MS2 at a resolution power of 17,500. The sample volumes of 10 μl were injected which contained 150,000 cells. Data acquisition and analysis were carried out by Xcalibur 4.0 software and Tracefinder 2.1 software, respectively (both from Thermo Fisher Scientific). For metabolite concentrations, the samples (containing dried extraction of 500,000 cells) were resuspended in 70 μl of 50% acetonitrile containing 25 pg/μl D~5~-2-hydroxyglutarate disodium salt (Toronto Research Chemical). 25 μl of each sample were analyzed by High-Performance Liquid Chromatography and High-Resolution Mass Spectrometry and Tandem Mass Spectrometry (HPLC-MS/MS) as described above. Cellular quantities of 2-HG, succinate, α-KG, and fumarate were calculated using the ratio measured metabolite to the known amount of D~5~-2-hydroxyglutarate disodium salt spiked into the samples. Concentrations where determined using the average cellular diameter of each sample which was measured with the Cellometer K2 Counter (Nexcelon) and assuming 70% of the volume of the cell was water.

Oxygen consumption (OCR) and extracellular acidification rate (ECAR) measurements {#S10}
---------------------------------------------------------------------------------

OCR and ECAR were measured using the XF96 extracellular flux analyzers (Seahorse Bioscience). Basal mitochondrial respiration was measured by subtracting the OCR values after treatment with 1 μM antimycin A (Sigma) and 1 μM rotenone (Sigma) from the initial cellular measurements. ATP-coupled respiration was determined by treatment with 1 μM oligomycin A (Sigma), by the subtraction of oligomycin A values from basal respiration. Maximal mitochondrial respiration (post-CCCP respiration) was determined by subtracting the OCR after treatment with antimycin and rotenone as above from the OCR measured following treatment with 10μM Carbonyl cyanide 3-chlorophenylhydrazone (CCCP-Sigma). Experiments were performed in RPMI lacking phenol red and bicarbonate supplemented with 0.5% dialyzed serum, 11 mM glucose and 2 mM glutamine according to Seahorse Bioscience's instructions. Basal glycolytic rate was determined by subtracting ECAR measurement after treatment with 25mM 2-deoxyglucose (2-DG, Sigma) from the initial measured ECAR. Total glycolytic capacity was obtained by subtracting the ECAR following treatment with 25mM 2-DG from the ECAR measured after treatment with 1 μM oligomycin A. All OCR and ECAR measurements were performed on 300,000 freshly FASC sorted T~reg~ cells (CD4^+^ Foxp3-YFP^+^ CD25^+^ cells for 3-week-old mice; CD4^+^ Foxp3-GFP^+^ TdTomato-RFP^+^ for adult QFi animals). Freshly sorted T~reg~ cells were adhered to the seahorse analysis plate using Cell Tak (Corning) per the Seahorse Biosciences instructions.

NAD+/NADH Measurements {#S11}
----------------------

NAD+/NADH measurements were done using the NAD/NADH Glo Assay kit from (Promega). 200.000 cells were extracted in 50 μL ice cold lysis buffer (1% Dodecyltrimethylammonium bromide (DTAB) in 0.2 N NaOH diluted 1:1 with PBS), and immediately frozen at −80°C. To measure NADH, 25 μL of samples were incubated at 75°C for 30 min where basic conditions selectively degrade NAD+. To measure NAD+, 25 μL of samples and 12.5 μL 0.4 N HCl were incubated at 60°C for 15 min, where acidic conditions selectively degrade NADH. Following incubations, samples were allowed to equilibrate to room temperature and then quenched by neutralizing with 25 μL 0.25 M Tris in 0.2 N HCl (NADH) or 12.5 μL 0.5 M Tris base (NAD+). 50μl of NAD/NADH-Glo™ Detection Reagent was added to each well. Luminescence was measured after 3h incubation at room temperature.

Adoptive transfer colitis model {#S12}
-------------------------------

Rag-1-deficient animals where acquired from Jackson lab (Cat\# 002216) and colitis was induced based on the protocol described by Workman and collegues^[@R41]^. In brief, CD45.1^+^ CD4^+^ CD45rb^hi^ CD25^−^ (T~eff~) and CD45.2^+^ CD4^+^ Foxp3-YFP^+^ CD25^+^ (T~reg~) cells were isolated and 400,000 T~eff~ cells with or without 100,000 T~reg~ cells were injected into Rag-1-deficient mice. Mice were weighed at the time of injection and monitored 3 times weekly for 12 weeks or until mice lost 20% of their initial body weight. Colons were isolated and fixed overnight in 10% neutral-buffered formalin. Following overnight fixations, colons were wrapped and stored in PBS at 4C until embedding in paraffin.

B16 Melanoma Model {#S13}
------------------

100,000 B16-F10 (ATCC) were subcutaneously injected into the flank of 8--12-week old mice. One day prior (−1) to tumor injection and 1, 3, 6, 9, and 12 days after injection of tumors mice were treated with 320mg/kg of tamoxifen dissolved in corn oil by oral gavage. Tumor development and progression was monitored by caliper measurement 3 times per week. Mice were euthanized prior to tumors reaching 1500mm^3^.

Statistics and reproducibility {#S14}
------------------------------

*P* values were calculated as described in each individual figure legend using Graphpad Prism 7 (Graphpad Software) or R. Data are presented as mean ± standard deviation unless specifically stated in the figure legend. Numbers of biological and/or technical replicates are stated in the figure legends. Randomization was not performed in animal experiments; however, littermates were used whenever possible. The investigators were not blinded to allocation during experiments and outcome assessment. All images are representative of at least three independent experiments on mice of the same genotype. Immunoblots are representative of two independent experiments total \>6 individual mice of each genotype pooled in at least 4 samples. No statistical method was used to predetermine sample size and experiments were not randomized.

Data availability {#S15}
-----------------

All RNA-seq and DNA methylation data have been deposited Gene Expression Omnibus (GEO) under accession code GSE120452. All other data from the manuscript are available from the corresponding author on request.

Extended Data {#S16}
=============

![Loss of RISP in T~reg~ cells results in T cell proliferation, activation and immune infiltration into multiple organs.\
**a**, Representative images of skin changes observed in RISP KO (top) animals compared to RISP WT. **b**,**c**, Weight (**b**) and total cellularity (**c**) of the spleen (RISP WT n=10, RISP KO n=9), lymph nodes (RISP WT n=10, RISP KO n=9), and thymus (RISP WT n=5, RISP KO n=5) in RISP WT and KO mice at 3 weeks of age. **d**, Representative 10X-images from 3-week-old RISP WT and KO animals. The RISP KO thymuses show thinning of the thymic cortex secondary to lymphoid depletion. Significant perivascular inflammation can be observed in the lung and liver, while dermal thickening and profound inflammation was seen in the skin. **e**, **f**, CD4^+^ (**e**, RISP WT n=10, RISP KO n=9) and CD8^+^ (**f**, RISP WT n=10, RISP KO n=9) T cell numbers in the spleen and lymph nodes in 3-week-old mice. **g**, **h**, Percentage of naïve (CD62L^+^ CD44^−^) and effector (CD62L^−^ CD44^+^) cells of the total CD4^+^ (**g**, RISP WT n=5, RISP KO n=5) and CD8^+^ (**h**, RISP WT n=5, RISP KO n=5) T cells. Images are representative of at least three mice harvested on independent days. Data represent mean ± SD and were analyzed with (**b, c**) two-tailed *t*-test (\*\*p\<.001, specific p-values displayed in supplemental source data) or with (**e-h**) multiple two-tailed *t-*tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 1%. Each cell type was analyzed individually, without assuming a consistent SD (\*\*q\<.001, specific q-values displayed in supplemental source data). All data points on graphs represent individual animals isolated and analyzed on at least 2 separate days.](nihms-1514193-f0005){#F5}

![Mice with regulatory T cells deficient in RISP do not display thymic dysfunction early in life.\
**a**, **b**, Thymic weight (**a**) and total thymocyte number (**b**) observed from 10-day-old RISP KO (n=5) and WT (n=5) mice. **c**, Absolute cell numbers of double-negative (CD4^−^ CD8^−^, DN), double-positive (CD4^+^ CD8^+^, DP), CD8 single-positive (CD4^−^ CD8^+^, CD8 SP), and CD4 single-positive (CD4^+^ CD8^−^, CD4 SP) populations from the thymuses of 10-day old RISP KO (n=5) and WT (n=5) mice. **d**, Foxp3-YFP^+^ and Foxp3-YFP^+^ CD4 SP absolute cell numbers in the thymuses of 10-day old RISP KO (n=5) and WT (n=5) animals..**e**, Representative contour plot of the T~reg~ cell compartment in the superficial lymph nodes at 3 weeks of age. Contour plots are representative of at least three independent experiments totaling at least 5 mice. Numbers in dot plot quadrants indicate percentage of cells. Images are representative of at least three mice harvested on independent days. Data represent mean ± SD and were analyzed with (**a, b**) two-tailed *t*-test (specific p-values displayed in supplemental source data) or with (**c, d**) multiple two-tailed *t-*tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 1%. Each cell type was analyzed individually, without assuming a consistent SD (specific q-values displayed in supplemental source data). All data points on graphs represent individual animals isolated and analyzed on at least 2 separate days.](nihms-1514193-f0006){#F6}

![Loss of RISP does not significantly impair expression of classic T~reg~ cell markers, activation markers and proliferation, but impairs T~reg~ suppressive function.\
**a**, Expression of CD25 on CD4^+^ Foxp3-YFP^+^ cells isolated from the spleen and lymph nodes of 21-day-old RISP KO and RISP WT animals. **b**, Surface expression of CTLA-4 and GITR on CD4^+^ Foxp3-YFP^+^ CD25^+^ cells from 3-week-old RISP KO and WT mice. **c**, Cellular expression of EOS and Helios from CD4^+^ Foxp3^+^ CD25^+^ cells isolated from the spleen and lymph nodes. **d**, Surface expression of activation makers CD44, CD69, CD103, ICOS, and OX40 on CD4^+^ Foxp3-YFP^+^ CD25^+^ cells isolated from the spleen and lymph nodes. **e**, Ki-67 expression in CD4^+^ Foxp3^+^ CD25^+^ from the spleen and lymph nodes. **f**, Percentage of central (cT~reg~) verses effector T~reg~ (eT~reg~) cells in the spleen and lymph nodes of 3-week-old RISP KO (n=4 for both tissues) and RISP WT (spleen n=6, LN n=8) mice with representative contour plot. **g**, Representative histograms of CD69, CD73, and Nrp1 expression on cT~reg~ and eT~reg~ cells isolated from lymph nodes of 3-week-old RISP KO and RISP WT mice. **h**, Cell trace violet (CTV) dilution in CD8^+^ effector T cells stimulated to proliferate with varying ratios of RISP WT and RISP KO CD4^+^ Foxp3-YFP^+^ CD25^+^ cells isolated from the lymph nodes of 3-week old mice. **i**, Representative images of the colons from Rag1-null mice 1 month following adoptive transfer. Images are representative of at least three mice harvested on independent days. Contour plots are representative at least three independent experiments totaling at least 4 mice. Numbers in dot plot quadrants indicate percentage of cells. Histograms are representative of at least three independent experiments totaling at least five mice (WT=Blue, KO=Red). Numbers on histograms represent mean fluorescence intensity (MFI) of depicted samples. Y-axis of all histograms represents % of max. Data in panel (**f**) analyzed with multiple two-tailed *t-*tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 1%. Each cell type was analyzed individually, without assuming a consistent SD (specific q-values displayed in supplemental source data). All data points on graphs represent individual animals isolated and analyzed on at least 2 separate days.](nihms-1514193-f0007){#F7}

![Loss of complex III subunit QPC in T~reg~ cells gives rise to a lethal inflammatory disorder.\
**a**, Scheme illustrating the strategy utilized to generate *Uqcrq* floxed and excised alleles. **b**, Expression of *Uqcrq* mRNA in CD4^+^ Foxp3-YFP^+^ CD25^+^ cells from 21-day-old QPC KO (n=4) relative to QPC WT (n=4) mice. *Uqcrq* expression was normalized to expression of *Rpl19*. **c**,**d**, Oxygen consumption rate (OCR) (**c**) and extracellular acidification rate (ECAR) (**d**) of CD4^+^ Foxp3*-*YFP^+^ CD25^+^ cells isolated from 3-week-old QPC WT (n=3) and QPC KO (n=3) mice **e**, Survival of QPC WT (n=8) and QPC KO (n=9) animals (p=.0002 using one-sided log-rank test). **f-h**, Weights of spleens (**f**), lymph nodes (**g**), and thymuses (**g**) from 3-week-old QPC WT (n=4) and KO (n=5) mice. **i**-**j**, Total cellularity of the spleen (**i**), lymph nodes (**j**), and thymuses (**k**) from 3-week-old QPC WT (n=4) and KO (n=5) mice. **l**,**m**, CD4^+^ (**l**) and CD8^+^ (**m**) T cell numbers in the spleen and lymph nodes in 3-week-old QPC WT (n=4) and QPC KO (n=5) animals. **n**,**o**, Percentage of naïve (CD62L^+^ CD44^−^) and effector (CD62L^−^ CD44^+^) cells of the total CD4^+^ (**n**) and CD8^+^ (**o**) T cells in 3-week-old QPC WT (n=4) and QPC KO (n=5) animals. **p**, Absolute number of T~reg~ cells in the spleen and lymph nodes from 3-week-old QPC WT (n=4) and KO (n=5) animals. Data represent mean ± SD and were analyzed with (**b, f-k**) two-tailed *t*-test (\**p*\<.01, \*\*p\<.001, specific p-values displayed in supplemental source data) or with (**c,d, l-p**) multiple two-tailed *t-*tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 1%. Each cell type was analyzed individually, without assuming a consistent SD (\*q\<.01, \*\*q\<.001, specific q-values displayed in supplemental source data). All data points on graphs represent individual animals isolated and analyzed on at least 2 separate days.](nihms-1514193-f0008){#F8}

![Loss of QPC in T~reg~ cells impairs suppressive function without altering Foxp3 expression.\
**a**, Representative images of the spleen, superficial lymph nodes, mesenteric lymph nodes, and thymuses from QPC iKO animals compared to QPC iWT treated with tamoxifen for 28 days. **b**, **c**, Cellularity of the spleen (**b**) and lymph nodes (**c**) from QPC iWT (n=4) and QPC iKO (n=4) mice treated with tamoxifen for 28 days. **d**, 40X histological images of the skin from QPC iKO and QPC iWT animals. **e**, Percentage of CD4^+^ T cells (CD45^+^ CD4^+^), CD8^+^ T cells (CD45^+^ CD8^+^), T~reg~ cells (CD45^+^ CD4^+^ Foxp3-GFP^+^) and non-T leukocytes (CD45^+^ CD4^−^ CD8^−^) from the spleen and lymph nodes of QPC iWT (n=4) and QPC iKO (n=4) expressing tdTomato-RFP after 2 weeks of tamoxifen treatment every third day. **f**, Percentage of thymic epithelial cells (CD45^−^ EpCAM^+^) expressing tdTomato-RFP after 2 weeks of tamoxifen treatment every third day from QPC iWT (n=4) and QPC iKO (n=4). **g**, **h**, Total cellularity of the spleen (**g**) and lymph nodes (**h**) 3 months after 3 doses of tamoxifen from QPC iWT (n=4) and QPC iKO (n=4) animals. **i**, Representative dot plots of the splenic T~reg~ cell compartment in QPC iKO and QPC iWT at 3 months after tamoxifen treatment. Images are representative of at least three mice collected on 3 different days. (**f**) Numbers in quadrants indicate percentage of cells. (**b,c,e-h**) Data represent mean ± SD and were analyzed with (**b,c,f-h**) two-tailed *t*-test (\**P˂.05, \*\*P˂.01*, specific p-values displayed in supplemental source data*)* or (**e**) multiple two-tailed *t-*tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 1%. Each cell type was analyzed individually, without assuming a consistent SD (\*\*q\<.001, specific q-values displayed in supplemental source data). All data points on graphs represent individual animals isolated and analyzed on at least 2 separate days.](nihms-1514193-f0009){#F9}

![Loss of RISP in T~reg~ cells results in major alterations in gene expression including downregulation of known T~reg~ cell suppressive genes in 21-day-old mice.\
**a**, Hierarchical clustering showing changes in gene expression in CD4^+^ Foxp3-YFP^+^ CD25^+^ cells isolated from 3-week-old RISP KO (n=4) and RISP WT (n=4) mice. **b**, Volcano plot showing differential gene expression in CD4^+^ Foxp3-YFP^+^ CD25^+^ cells isolated from 3-week-old RISP KO (n=4) and RISP WT (n=4) mice. *Uqcrsf1* (gene encoding for RISP) not shown on plot (logFC=−4.83, −log~10~(*p*-value)=203). **c**, Normalized enrichment scores from gene set enrichment analysis from the hallmark gene set in the molecular signatures database v6.0 comparing gene-set generated from panel a. **d**, Heat map of T~reg~ cell signatures genes that are differentially expressed (adj. P\<.01) in RISP KO (n=4) versus RISP WT (n=4) animals. **e**, Surface expression of CD73, Nrp1, PD1, and Tigit on CD4^+^ Foxp3-YFP^+^ CD25^+^ cells isolated from the spleen and lymph nodes of 3-week-old RISP KO and RISP WT animals. Histograms are representative at least two independent experiments totaling at least 4 mice. Numbers above histograms represent mean fluorescence intensity (MFI) of depicted samples. Data in panels **a-d**, are from one RNA sequencing experiment. CD4^+^ Foxp3-YFP^+^ CD25^+^ cells from RISP WT (n=4) and RISP KO (n=4) animals were isolated on different days. cDNA library production and sequencing was performed only one time and all 8 RNA samples were prepared together.](nihms-1514193-f0010){#F10}

![Mice that contain a T~reg~ cell compartment with chimeric RISP-loss do not develop an inflammatory disease but do display a cell autonomous impairment in expression of a T~reg~-specific transcription profile.\
**a,b**, Total number of cells in the spleen (**a**) and lymph nodes (**b**) of adult (8--12 weeks) RISP chimeric KO (n=4) and chimeric WT (n=4) mice. **c**, CD4^+^ and CD8^+^ T cell numbers in the spleen and lymph nodes of adult RISP chimeric KO (n=4) and chimeric WT (n=4) mice. **d**, Percentage of total CD4^+^ cells that are either CD4^+^ Foxp3-YFP^+^ CD25^+^ (chimeric T~reg~ cells) and CD4^+^ Foxp3^+^ CD25^+^ (total T~reg~ cells) from adult RISP chimeric KO (n=4) and RISP chimeric WT (n=4) mice. **e**, Percentage of chimeric T~reg~ cells of all T~reg~ cells present in adult RISP chimeric KO (n=4) and chimeric WT (n=4) animals. **f**,**g**, Ratio of surface expression of CD44, ICOS (**d**) and CTLA-4 (**e**) on chimeric T~reg~ cells (CD4^+^ Foxp3-YFP^+^ CD25^+^) relative to CD4^+^ Foxp3-YFP^−^ CD25^+^ (wild-type T~reg~ cells) cells from pooled samples of the spleen and lymph node in adult RISP chimeric KO (n=4) and RISP chimeric WT mice (n=4). **h**, Hierarchical clustering showing changes in gene expression in CD4^+^ Foxp3-YFP^+^ CD25^+^ cells isolated from adult RISP chimeric KO (n=4) and chimeric WT mice (n=4). **i**, Normalized enrichment scores from gene set enrichment analysis from the hallmark gene set in the molecular signatures database v6.0 on data set shown in panel h. **j**, Ratio of surface expression of CD73 and Nrp1, on chimeric T~reg~ cells relative wild-type T~reg~ cells from pooled samples of the spleen and lymph node in adult RISP chimeric KO (n=4) and RISP chimeric WT (n=4) mice. **k**, Venn-diagram displaying overlap of differential expressed genes (adj. p\<.01) from T~reg~ cells (CD4^+^ Foxp3-YFP^+^ CD25^+^) isolated from 21-day-old RISP KO (n=4) and RISP WT (n=4) animals (RISP 21-day-old) versus chimeric T~reg~ cells (CD4^+^ Foxp3-YFP^+^ CD25^+^) isolated from adult RISP chimeric KO (n=4) and RISP chimeric WT (n=4) mice. *P* values were calculated using hypergeometric similarity measure. (**a-f,g,j)** Data represent mean ± SD and were analyzed with **(a,b,f,g,j)** two-tailed *t*-test (\**P˂.05, \*\* P˂.01*, specific p-values displayed in supplemental source data) or (**c,d,e**) multiple two-tailed *t-*tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 1%. Each cell type was analyzed individually, without assuming a consistent SD (\*\*q\<.001, specific q-values displayed in supplemental source data). All data points on graphs represent individual animals isolated and analyzed on at least 2 separate days. Data in panels **h**,**i** are from one RNA sequencing experiment. CD4^+^ Foxp3-YFP^+^ CD25^+^ cells from RISP chimeric WT (n=4) and RISP chimeric KO (n=4) animals were isolated on different days. cDNA library production and sequencing was performed only one time and all 8 RNA samples were prepared together.](nihms-1514193-f0011){#F11}

![Loss of RISP in T~reg~ cells alters DNA methylation without affecting the *Foxp3* locus in 3-week-old mice.\
**a**, **b**, CpG methylation around the transcriptional start site (TSS) and transcriptional end site (TES) (**a**) and the start (S) and end (E) of T~reg~ cell-specific super-enhancer elements with 20 kb of flanking sequence (**b**) in CD4^+^ Foxp3-YFP^+^ CD25^+^ cells from 3-week-old RISP KO (n=4) and RISP WT (n=4) animals. **c**, DNA methylation status of the super-enhancer associated with the *Foxp3* locus in RISP KO and RISP WT T~reg~ cells. **d**,**e**, Percentage of methylated CpGs around the TSS of differentially downregulated (**d**) and upregulated (**e**) genes (log~2~FC≥2, FDR q-value\<.05) from [Extended Data Figure 6](#F10){ref-type="fig"}. (**a**,**d,e**) mRRBS data were smoothed with sliding window size of 20 CpGs and a step of 10 CpGs for sites with \>5X coverage. (**b**) T~reg~ cell-specific super-enhancer data were normalized over 1-kb windows. Average CpG methylation of n=3 biological replicates per group is shown. **f**, Venn diagram analysis partitioning differentially methylated loci (DML) and differentially expressed genes (DEG). **g**, Cumulative distribution function of differentially methylated CpGs within 100 kilobases of 87 DEG that were down-regulated (log~2~ fold-change≤0) in chimeric KO T~reg~ cells. Data points represent average methylation at each gene locus. **h**, Heatmap displaying the methylation state (beta) of differentially methylated CpGs at gene loci that were both hypermethylated and differentially down-regulated (adj-p\<.01) in the chimeric KO T~reg~ cells. (**c**) Data represent mean ± SEM and were analyzed with two-tailed t-test. (**a-e**) CD4^+^ Foxp3-YFP^+^ CD25^+^ cells from RISP WT (n=3) and RISP KO (n=3) animals were isolated on different days. Further processing and sequencing was performed with all 6 samples together. (**f-h**) CD4^+^ Foxp3-YFP^+^ CD25^+^ cells from RISP chimeric WT (n=4) and RISP chimeric KO (n=4) animals were isolated on different days. Further processing and sequencing was performed with all 8 samples together.](nihms-1514193-f0012){#F12}

![Metabolite alterations in complex III-deficient T~reg~ cells.\
**a**, The ratio of NAD+/NADH in T~reg~ (CD4^+^ Foxp3-GFP^+^ tdTomato-RFP^+^) cells isolated from QPC iWT (n=5) or QPC iKO (n=6) 6 weeks after receiving 3 doses of tamoxifen. **b**, Calculated intracellular concentration of 2-HG, succinate, α-KG, and fumarate in T~reg~ (CD4^+^ Foxp3-GFP^+^ tdTomato-RFP^+^) cells isolated from QPC iWT (5) or QPC iKO (5) 6 weeks after receiving 3 doses of tamoxifen. **c**,**d**, LC-MS quantified levels of specific complex III dependent (**c**), and TCA cycle (**d**) metabolites in CD4^+^ Foxp3-YFP^+^ CD25^+^ cells isolated from 3-week-old RISP KO and WT mice. Data represent mean ± SD and were analyzed by (**a,b**) two-tailed *t*-test (*\*\*p˂.01*, respectively; specific *p*-values displayed in supplemental source data) or (**c,d**) multiple two-tailed *t-*tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 1%. Each metabolite was analyzed individually, without assuming a consistent SD (\*Q\<.01, \*\*Q\<.001; specific q-values displayed in supplemental source data). All data points on graphs represent individual animals isolated and analyzed on at least 2 separate days.](nihms-1514193-f0013){#F13}

![Elevated glycolytic flux does not phenocopy complex III inhibition in regulatory T cells.\
**a**, Venn diagram displaying overlap of differentially expressed genes (adj. p\<.01) from T~reg~ cells (CD4^+^ Foxp3-YFP^+^ CD25^+^) isolated from 8-to-12-week-old RISP chimeric KO and RISP chimeric WT mice T~reg~ cells (CD4^+^ Foxp3-YFP^+^ CD25^+^) verses T~reg~ cells overexpressing GLUT1 isolated from adult animals. *P* values were calculated using hypergeometric similarity measure. **b**, Oxygen consumption rate (OCR) of T~reg~ (CD4^+^ Foxp3-YFP^+^ CD25^+^) cells treated with 1μM Piericidin, 500μM 3-NPA, or 1μM antimycin A for 4 hours. Data represent mean ± SD and were analyzed 1-way ANOVA with Dunnett's test for multiple comparisons (\**adj-p*\<.05 *\*\*adj-p˂.01*, respectively; specific *p*-values displayed in supplemental source data). All data points on graphs represent individual animals isolated and analyzed on at least 2 separate days.](nihms-1514193-f0014){#F14}
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![Loss of complex III in T~reg~ cells results in a lethal inflammatory disorder and loss of T~reg~ cell suppressive function.\
**a**, RISP and β-actin protein expression in CD4^+^ Foxp3-YFP^+^ CD25^+^ cells isolated from 3-week-old RISP WT and RISP KO mice. **b**,**c,** (**b**) Oxygen consumption rate (OCR) and (**c**) extracellular acidification rate (ECAR) of CD4^+^ Foxp3*-*YFP^+^ CD25^+^ cells isolated from 3-week old RISP WT (n=6) and RISP KO mice (n=5). **d**, Representative image of 3-week-old RISP WT and RISP KO mice. **e**, Survival of RISP WT (n=8) and RISP KO (n=11) animals (p=.0009 using one-sided log-rank test). **f**, Representative images of spleens, lymph nodes, and thymuses from 3-week-old animals. **g**, Number of T~reg~ cells in the spleen and lymph nodes in 3-week-old RISP KO (n=5) and RISP WT (n=5) mice. **h**, Survival of Rag1-deficient mice following adoptive transfer of CD4^+^ CD45rb^hi^ CD25^−^ cells (T~eff~) alone (n=8) or with CD4^+^ Foxp3-YFP^+^ CD25^+^ cells isolated from 3-week-old RISP WT (n=6) and RISP KO mice (n=6). Animals were removed from the experiment after losing 20% of their pre-transfer body weights (p=.0156 using one-sided log-rank test). Images are representative of at least three mice harvested on independent days. Data (**b,c,g**) represent mean ± SD and were analyzed with multiple two-tailed *t-*tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 1% unless otherwise stated. Each cell type was analyzed individually, without assuming a consistent SD (\*Q\<.01, \*\*Q\<.001, specific q-values displayed in supplemental source data). All data points on graphs represent individual animals isolated and analyzed on at least 2 separate days.](nihms-1514193-f0001){#F1}

![Loss of complex III in T~reg~ cells impairs suppressive function without altering Foxp3 expression.\
**a-c,** *Uqcrq* mRNA expression (**a**), OCR (**b**) and ECAR (**c**) of CD4^+^ Foxp3-GFP^+^ TdTomato-RFP^+^ cells isolated from QPC iKO (n=5) and QPC iWT (n=5) mice 6-weeks after 3 doses of tamoxifen. **d**, Representative images of QPC iKO animals compared to QPC iWT treated with tamoxifen for 28 days. **e**, Percentage of CD4^+^, CD8^+^, and CD4^+^ Foxp3-GFP^+^ in the spleen and lymph nodes expressing high levels of CD44 from QPC iWT (n=4) and QPC iKO (n=4) mice treated with tamoxifen. **f**, Percentage of post-tamoxifen generated (Foxp3-GFP^+^ tdTomato-RFP^−^) T~reg~ cells, pre-tamoxifen generated stable (Foxp3-GFP^+^ tdTomato-RFP^+^) T~reg~ cells, and previously expressing Foxp3^+^ (Foxp3-GFP^−^ tdTomato-RFP^+^) T cells of the total CD4^+^ T cell compartment from QPC iWT (n=4) and iKO (n=4) mice 3 months after 3 doses of tamoxifen. **g**, Ratio of Foxp3-GFP^−^ tdTomato-RFP^+^ to Foxp3-GFP^+^ tdTomato-RFP^+^ cells from QPC iWT (n=4) and QPC iKO (n=4) mice 3 months after tamoxifen. **h**, Growth of B16 melanoma cells in QPC iWT and QPC iKO mice (n=10 for both groups). Tamoxifen was administered on day −1, 1, 3, 6, 9, and 12 post tumor injection. Images are representative of at least three mice collected on 3 different days. Data represent mean ± SD and were analyzed with (**a**) two-tailed *t*-test (*\*\* P˂.001*, specific *p*-values displayed in supplemental source data), with (**b,c,e-g**) multiple two-tailed *t-*tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 1%. Each cell type was analyzed individually, without assuming a consistent SD (\*Q\<.01, \*\*Q\<.001, specific q-values displayed in supplemental source data) Data in panel **h** was analyzed with two-way ANOVA with a Turkey test for multiple comparisons (*\*\* Adj-p˂.0001*, specific *p*-values displayed in supplemental source data). All data points on graphs represent individual animals isolated and analyzed on at least 2 separate days](nihms-1514193-f0002){#F2}

![Complex III deficiency in T~reg~ cells results in a cell autonomous impairment in expression of genes associated with T~reg~ cell suppressive function along with DNA hypermethylation.\
**a**, The absolute number of CD4^+^ Foxp3-YFP^+^ CD25^+^ (chimeric T~reg~ cells) and CD4^+^ Foxp3^+^ CD25^+^ (total T~reg~ cells) from adult RISP chimeric KO (n=4) and RISP chimeric WT (n=4) mice. **b**, Volcano plot showing differential gene expression in CD4^+^ Foxp3-YFP^+^ CD25^+^ cells isolated from adult RISP chimeric KO (n=4) and RISP chimeric WT (n=4) mice. **c**, Heat map of T~reg~ cell signatures genes that are differentially expressed (adj. P\<.01) in RISP chimeric KO (n=4) versus RISP chimeric WT (n=4) animals. **d**, Cumulative distribution function of 17,588 differentially methylated CpGs comparing chimeric T~reg~ cells from RISP chimeric WT (n=4) and Treg-specific RISP-deficient chimeric KO (n=4) mice. Estimated CpG methylation is expressed as beta scores with 0 being unmethylated and 1 fully methylated. **e**, Metagene analysis of T~reg~ cell-specific super-enhancer methylation from dataset in panel **d**. Data (**a**) represent mean ± SD and were analyzed with multiple two-tailed *t-*tests using a two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 1%. Each cell type was analyzed individually, without assuming a consistent SD (Specific q-values displayed in supplemental source data). Data points on graphs represent individual animals isolated and analyzed on at least 2 separate days. Data in panels **b-e** are from one RNA sequencing (**b,c**) and one mRRBS (**d,e**) experiment respectively. CD4^+^ Foxp3-YFP^+^ CD25^+^ cells from RISP chimeric WT (n=4) and RISP chimeric KO (n=4) animals were isolated on different days. Further processing and sequencing was performed with all 8 samples together.](nihms-1514193-f0003){#F3}

![Inhibition of different electron transport chain complexes in regulatory T cells results in distinct alterations in metabolites and gene expression.\
**a**, The ratio of NAD+/NADH in T~reg~ cells isolated from 21-day-old RISP WT (n=6) or RISP KO (n=6) mice. **b**, Calculated intracellular concentration of 2-HG, succinate, α-KG, and fumarate in T~reg~ cells isolated from 21-day-old RISP WT (n=6) or RISP KO (n=5, n=4 for fumarate) mice. **c,** Calculated intracellular concentration of 2-hydroxyglutarate (2-HG) and succinate in untreated T~reg~ cells (n=4) or treated with 1μM Piericidin (n=4), 500μM 3-NPA (n=4), or 1μM antimycin A (n=4) for 24 hours *in vitro*. **d**, Hierarchical clustering showing changes in gene expression (adj-*p*\<.01) in CD4^+^ Foxp3-YFP^+^ CD25^+^ cells treated with mitochondrial inhibitors for 24 hours. Data represent mean ± SD (**a-c)** and were analyzed with (**a,b**) two-tailed *t*-test (\**p*\<.05 *\*\*p˂.01*, respectively; specific *p*-values displayed in supplemental source data), with (**c**) 1-way ANOVA with Dunnett's test for multiple comparisons (\**adj-p*\<.05 *\*\*adj-p˂.01*, respectively; specific *p*-values displayed in supplemental source data). All data points on graphs represent individual animals isolated and analyzed on at least 2 separate days. Data in panels **d** is from one RNA sequencing experiment. CD4^+^ Foxp3-YFP^+^ CD25^+^ cells from RISP WT (n=4) animals were isolated and treated with inhibitors on two different days. cDNA library production and sequencing was performed only one time and all 16 RNA samples were prepared together.](nihms-1514193-f0004){#F4}
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